您的位置: 专家智库 > >

国家自然科学基金(30871122)

作品数:3 被引量:8H指数:2
相关作者:郑君文高亚东杨炯耿爽邹进晶更多>>
相关机构:武汉大学更多>>
发文基金:国家自然科学基金中国博士后科学基金教育部留学回国人员科研启动基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 3篇中文期刊文章

领域

  • 3篇医药卫生

主题

  • 3篇平滑肌
  • 3篇平滑肌细胞
  • 3篇肌细胞
  • 2篇平滑肌细胞增...
  • 2篇气道
  • 2篇气道平滑肌
  • 2篇气道平滑肌细...
  • 2篇气道平滑肌细...
  • 2篇钙通道
  • 1篇蛋白
  • 1篇蛋白激酶
  • 1篇蛋白激酶C
  • 1篇动脉
  • 1篇动脉平滑肌细...
  • 1篇选择性抑制剂
  • 1篇抑制剂
  • 1篇增殖
  • 1篇制剂
  • 1篇转化生长因子
  • 1篇转化生长因子...

机构

  • 2篇武汉大学

作者

  • 2篇杨炯
  • 2篇高亚东
  • 2篇郑君文
  • 1篇邹进晶
  • 1篇耿爽

传媒

  • 1篇中国病理生理...
  • 1篇武汉大学学报...
  • 1篇Journa...

年份

  • 1篇2012
  • 1篇2011
  • 1篇2010
3 条 记 录,以下是 1-3
排序方式:
蛋白激酶C活性下调对钙库操纵的钙通道活性和气道平滑肌细胞增殖的作用被引量:4
2010年
目的:研究蛋白激酶C(PKC)活性下调对大鼠气道平滑肌细胞(ASMCs)的Ca2+库操纵的Ca2+通道(SOC)和ASMCs增殖的影响。方法:分离培养大鼠支气管平滑肌细胞;利用激光共聚焦显微镜测定ASMCs的fluo-3/AM的荧光信号;利用长时间暴露于PKC活化剂诱导PKC活性下调,观察PKC活性下调对ASMCs的SOC通道和增殖的影响;Alamar blue还原率测定法测定ASMCs的增殖。结果:PKC激活剂PMA(10μmol/L)和PDBu(1μmol/L)作用24h下调PKC活性后可以抑制ASMCs的增殖,PKC抑制剂chelerythrine同样抑制ASMCs的增殖;PKC活性下调和chelerythrine均可以抑制ASMCs的SOC通道活性;小剂量PKC激活剂PMA(100nmol/L)可以促进ASMCs的增殖,这种作用被SOC通道抑制剂SKF-96365抑制。结论:PKC活性下调或抑制导致SOC通道的活性下降,表明PKC可能参与了SOC通道功能调控;SOC通道开放可能参与了PKC促进ASMCs增殖的作用。
高亚东邹进晶郑君文耿爽杨炯
关键词:蛋白激酶CCA2+通道气道平滑肌细胞
钙库操纵的钙内流在转化生长因子-β_1促进气道平滑肌细胞增殖中的作用被引量:5
2011年
目的:探讨钙库操纵的钙内流(SOCE)在转化生长因子-β1(TGF-β1)促进气道平滑肌细胞(ASMCs)增殖中的作用。方法:体外培养大鼠ASMCs,以Fluo-3/AM为细胞内钙离子浓度示踪剂,观察ASMCs在TGF-β1作用后,细胞内基础钙离子浓度、钙释放和SOCE的变化;四甲基偶氮唑蓝(MTT)微量比色法测定TGF-β1对胎牛血清(FBS)刺激的大鼠ASMCs的增殖的促进作用,以及钙库操纵的钙通道(SOC)抑制剂SKF-96365、NiCl2组和LaCl3对这一作用的影响。结果:①在无钙溶液中,肌浆网钙泵抑制剂thapsigargin诱导ASMCs的钙释放,这一作用在TGF-β1(10μg/L)处理组高于对照组;同时,复钙后的SOCE幅度在TGF-β1处理组也高于对照组。②TGF-β1(10μg/L)可以促进2.5%FBS刺激的ASMCs的增殖(P<0.001),这一效应可以被钙通道抑制剂SKF-96365(10μmol/L)和NiCl2(100μmol/L)抑制,而钙通道抑制剂LaCl3则对TGF-β1的促增殖作用无显著作用(P>0.05)。结论:钙库操纵的钙内流可能参与了TGF-β1促进ASMCs增殖的作用,提示其可能是调控气道重塑的重要靶点。
郑君文高亚东杨炯
关键词:气道平滑肌细胞转化生长因子-Β1细胞增殖钙通道
Role of Protein Kinase C in the Activation of Store-operated Ca^(2+) Entry in Airway Smooth Muscle Cells被引量:1
2012年
Store-operated Ca2+ channels (SOCs) are plasma membrane Ca2+ permeable channels activated by depletion of intracellular Ca2+ store. Ca2+ entry through SOCs is known as store-operated Ca2+ entry (SOCE), which plays an important role in the functional regulation of airway smooth muscle cells (ASMCs). Protein kinase C (PKC) has been shown to have an activating or inhibiting effect on SOCE, depending on cell types and PKC isoforms that are involved. In ASMCs, the effect of PKC on SOCE has not been elucidated so far. In this study, the role of PKC in the activation of SOCE in rat ASMCs was examined by using Ca2+ fluorescence imaging technique. The results showed that acute application of PKC activators PMA and PDBu did not affect SOCE induced by the sarcoplasmic reticulum Ca2+-ATPase (SERCA) inhibitor thapsigargin. The non-selective PKC inhibitor chelerythrine significantly inhibited thapsigargin- and bradykinin-induced SOCE. RT-PCR assay identified PKCα, δ and ε isoforms in rat ASMCs. PKCα-selective inhibitor G6976 and PKCε-inhibiting peptide Epsilon-V1-2 had no effect on SOCE; by contrast, PKCδ-selective inhibitor rottlerin attenuated SOCE dramatically, suggesting that PKCδ was the major PKC isoform involved in the activation of SOCE in ASMCs. Moreover, PKC down-regulation by extended exposure to high doses of PMA or PDBu also reduced SOCE, confirming the essential role of PKC in the activation of SOCE in ASMCs. In addition, PKC down-regulation did not influence the expression of stromal interaction molecule 1 (STIM1) and Orai1, two elementary molecules in the regulation and activation of SOCs. These results identified PKCδ as an essential PKC isoform involved in the activation of SOCE, and confirmed that PKC regulates the function of ASMCs in a SOCE-dependent manner.
高亚东邹进晶耿爽郑君文杨炯
关键词:动脉平滑肌细胞钙通道选择性抑制剂
共1页<1>
聚类工具0